Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NGM BIOPHARMACEUTICALS INC
8 Apr 24
4
NGM BIOPHARMACEUTICALS INC
12 May 23
4
NGM BIOPHARMACEUTICALS INC
20 May 22
4
NGM BIOPHARMACEUTICALS INC
10 Jun 21
3
NGM BIOPHARMACEUTICALS INC
10 Jun 21
4
Merck & Co., Inc.
5 May 20
4
Merck & Co., Inc.
3 Mar 20
4
Merck & Co., Inc.
7 May 19
4
Merck & Co., Inc.
27 Feb 19
4
Merck & Co., Inc.
8 Nov 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 17.24 | 46,238 | 797.14 k | 0 |
5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.35 | 24,222 | 323.36 k | 0 |
5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.69 | 78,407 | 289.32 k | 0 |
10 May 23 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.69 | 78,407 | 289.32 k | 78,407 |